CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Podcast: How Sandoz plans to harness its “golden decade”

Positive
AI Analysis

Summary

Sandoz's chief commercial officer discusses the company's plans to develop a biosimilar-driven growth engine by 2040 as part of its strategic ambitions for the coming decade.

Importance:2/10
Sentiment:
0.30
biosimilarsstrategygrowthpodcast
Related Companies

Read the original article

Published by Pharmaceutical Technology on September 24, 2026 10:22 AM

Read Original